Paul Bleicher

Paul Bleicher is an experienced executive in the healthcare technology sector, currently serving as an Executive Partner at Ardan Equity, focusing on middle market healthcare software and data investments. As a Co-Founding Advisor at Petri, Bleicher supports funding formation-stage startups that bridge biology and engineering, while also holding a position on the Board of Directors for uMed, which automates the creation of prospective research registries. Bleicher's previous roles include Principal at Evident Health Strategies, Strategic Advisor and CEO of OptumLabs, and Chief Medical Officer at Humedica. Bleicher also founded and led Phase Forward, pioneering commercial electronic data capture for clinical trials. Academic qualifications include an MD and PhD in Microbiology from the University of Rochester School of Medicine and Dentistry, as well as extensive training at prestigious institutions like Harvard Medical School.